Furthermore, the prevalence of tau protein pathology positively correlates with cognitive impairment in AD, where a person with AD has increased levels of tau protein, hyperphosphorylated tau protein, and aggregated tau in their brain [111]. This evidence concerns the gene MAPT and Alzheimer disease.